🔗 Share this article Social Media Influencers Fueling Unofficial Trade for Unlicensed Slimming Medication An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations. Experimental Drug Acquiring Popularity Via Social Media Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are urged to message these profiles privately for source information, while also receiving discount codes. Active Trade on Messaging Platforms Additionally, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of next-day British shipping. Sellers promote the substance there before redirecting buyers to other platforms for purchases. Learning About Retatrutide Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic. Medical Experts Express Concerns However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering substances of uncertain source. Several professionals said the demand for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro. Legal Status and Enforcement Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012. Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment. Platform Reaction and Material Removal According to the social media company, the platform has removed violative content and banned related hashtags and search suggestions. The company said it was committed to maintaining the service safe and investing in strengthening enforcement strategies. Digital Trading Operations Research also found groups with up to 9,000 members selling retatrutide using the platform's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, populated with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at home. Within moments of joining one group, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage. Item Details and Costs Inside these communities, posts show black plastic packages with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.” Buyers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”. Service Oversight and Security Measures A spokesperson for the messaging service stated it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”. Medical Expert Cautions “People are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U. Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said. Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.” Manufacturer Statement A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to potentially significant health risks”.